168 related articles for article (PubMed ID: 36353565)
1. Prognostic value of PET/CT and MR-based baseline radiomics among patients with non-metastatic nasopharyngeal carcinoma.
Kulanthaivelu R; Kohan A; Hinzpeter R; Liu ZA; Hope A; Huang SH; Waldron J; O'Sullivan B; Ortega C; Metser U; Veit-Haibach P
Front Oncol; 2022; 12():952763. PubMed ID: 36353565
[TBL] [Abstract][Full Text] [Related]
2. Early risk-assessment of patients with nasopharyngeal carcinoma: the added prognostic value of MR-based radiomics.
Kim MJ; Choi Y; Sung YE; Lee YS; Kim YS; Ahn KJ; Kim MS
Transl Oncol; 2021 Oct; 14(10):101180. PubMed ID: 34274801
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive integrated analysis of MR and DCE-MR radiomics models for prognostic prediction in nasopharyngeal carcinoma.
Li H; Huang W; Wang S; Balasubramanian PS; Wu G; Fang M; Xie X; Zhang J; Dong D; Tian J; Chen F
Vis Comput Ind Biomed Art; 2023 Dec; 6(1):23. PubMed ID: 38036750
[TBL] [Abstract][Full Text] [Related]
4. Differences in Radiomics Signatures Between Patients with Early and Advanced T-Stage Nasopharyngeal Carcinoma Facilitate Prognostication.
Wu S; Li H; Dong A; Tian L; Ruan G; Liu L; Shao Y
J Magn Reson Imaging; 2021 Sep; 54(3):854-865. PubMed ID: 33830573
[TBL] [Abstract][Full Text] [Related]
5. Radiomics Analysis of PET and CT Components of PET/CT Imaging Integrated with Clinical Parameters: Application to Prognosis for Nasopharyngeal Carcinoma.
Lv W; Yuan Q; Wang Q; Ma J; Feng Q; Chen W; Rahmim A; Lu L
Mol Imaging Biol; 2019 Oct; 21(5):954-964. PubMed ID: 30671740
[TBL] [Abstract][Full Text] [Related]
6. Combination of clinical, radiomic, and "delta" radiomic features in survival prediction of metastatic gastroesophageal adenocarcinoma.
Krishna S; Sertic A; Liu ZA; Liu Z; Darling GE; Yeung J; Wong R; Chen EX; Kalimuthu S; Allen MJ; Suzuki C; Panov E; Ma LX; Bach Y; Jang RW; Swallow CJ; Brar S; Elimova E; Veit-Haibach P
Front Oncol; 2023; 13():892393. PubMed ID: 37645426
[TBL] [Abstract][Full Text] [Related]
7. Radiomics Analysis and Correlation With Metabolic Parameters in Nasopharyngeal Carcinoma Based on PET/MR Imaging.
Feng Q; Liang J; Wang L; Niu J; Ge X; Pang P; Ding Z
Front Oncol; 2020; 10():1619. PubMed ID: 33014815
[No Abstract] [Full Text] [Related]
8. Prognostic value of
Li J; Zhang B; Ge S; Deng S; Hu C; Sang S
Front Oncol; 2022; 12():1047905. PubMed ID: 36465340
[TBL] [Abstract][Full Text] [Related]
9. Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients.
Bologna M; Corino V; Calareso G; Tenconi C; Alfieri S; Iacovelli NA; Cavallo A; Cavalieri S; Locati L; Bossi P; Romanello DA; Ingargiola R; Rancati T; Pignoli E; Sdao S; Pecorilla M; Facchinetti N; Trama A; Licitra L; Mainardi L; Orlandi E
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33066161
[TBL] [Abstract][Full Text] [Related]
10. Nasopharyngeal Carcinoma Radiomic Evaluation with Serial PET/CT: Exploring Features Predictive of Survival in Patients with Long-Term Follow-Up.
Dmytriw AA; Ortega C; Anconina R; Metser U; Liu ZA; Liu Z; Li X; Sananmuang T; Yu E; Joshi S; Waldron J; Huang SH; Bratman S; Hope A; Veit-Haibach P
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804877
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Radiomic Features of
Zhou Y; Li J; Zhang X; Jia T; Zhang B; Dai N; Sang S; Deng S
Front Oncol; 2022; 12():834288. PubMed ID: 35198451
[TBL] [Abstract][Full Text] [Related]
12. [
Travaini LL; Botta F; Derenzini E; Lo Presti G; Ferrari ME; Airò Farulla LS; Radice T; Mazzara S; Tarella C; Pileri S; Raimondi S; Ceci F
Hematol Oncol; 2023 Oct; 41(4):674-682. PubMed ID: 37209024
[TBL] [Abstract][Full Text] [Related]
13. Utility of CT Radiomics and Delta Radiomics for Survival Evaluation in Locally Advanced Nasopharyngeal Carcinoma with Concurrent Chemoradiotherapy.
Huang YC; Huang SM; Yeh JH; Chang TC; Tsan DL; Lin CY; Tu SJ
Diagnostics (Basel); 2024 Apr; 14(9):. PubMed ID: 38732355
[TBL] [Abstract][Full Text] [Related]
14. Potential Added Value of PET/CT Radiomics for Survival Prognostication beyond AJCC 8th Edition Staging in Oropharyngeal Squamous Cell Carcinoma.
Haider SP; Zeevi T; Baumeister P; Reichel C; Sharaf K; Forghani R; Kann BH; Judson BL; Prasad ML; Burtness B; Mahajan A; Payabvash S
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32635216
[TBL] [Abstract][Full Text] [Related]
15. Tumor Prognostic Prediction of Nasopharyngeal Carcinoma Using CT-Based Radiomics in Non-Chinese Patients.
Intarak S; Chongpison Y; Vimolnoch M; Oonsiri S; Kitpanit S; Prayongrat A; Kannarunimit D; Chakkabat C; Sriswasdi S; Lertbutsayanukul C; Rakvongthai Y
Front Oncol; 2022; 12():775248. PubMed ID: 35155228
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and predictive value of radiomics features at MRI in nasopharyngeal carcinoma.
Bao D; Zhao Y; Liu Z; Zhong H; Geng Y; Lin M; Li L; Zhao X; Luo D
Discov Oncol; 2021; 12(1):63. PubMed ID: 34993528
[TBL] [Abstract][Full Text] [Related]
17. Interchangeability of radiomic features between [18F]-FDG PET/CT and [18F]-FDG PET/MR.
Vuong D; Tanadini-Lang S; Huellner MW; Veit-Haibach P; Unkelbach J; Andratschke N; Kraft J; Guckenberger M; Bogowicz M
Med Phys; 2019 Apr; 46(4):1677-1685. PubMed ID: 30714158
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of [18F]-FDG PET/CT Radiomics Combined with Sarcopenia Status among Patients with Advanced Gastroesophageal Cancer.
Hinzpeter R; Mirshahvalad SA; Kulanthaivelu R; Ortega C; Metser U; Liu ZA; Elimova E; Wong RKS; Yeung J; Jang RW; Veit-Haibach P
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358733
[TBL] [Abstract][Full Text] [Related]
19. Gastro-Esophageal Cancer: Can Radiomic Parameters from Baseline
Hinzpeter R; Mirshahvalad SA; Kulanthaivelu R; Kohan A; Ortega C; Metser U; Liu A; Farag A; Elimova E; Wong RKS; Yeung J; Jang RW; Veit-Haibach P
Diagnostics (Basel); 2024 Jun; 14(11):. PubMed ID: 38893731
[TBL] [Abstract][Full Text] [Related]
20. PET/CT-based radiomics of mass-forming intrahepatic cholangiocarcinoma improves prediction of pathology data and survival.
Fiz F; Masci C; Costa G; Sollini M; Chiti A; Ieva F; Torzilli G; Viganò L
Eur J Nucl Med Mol Imaging; 2022 Aug; 49(10):3387-3400. PubMed ID: 35347437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
